The New Face of Pharma Marketing

healthins2Health care has endured a multitude of changes in the past year that have reshaped how the industry is approaching a former stalwart in health care marketing: pharmaceuticals. The Danbury, Conn.-based IMS Institute for Healthcare Informatics estimates that global spending on medicine will reach nearly $1.3 trillion by 2018—an almost 30% increase over 2013. Today’s pharma marketers, as a result, are adapting in the face of evolving market forces and government regulations to expand their target markets and provide value-added services to patients and providers.

Read the article in its entirety.  

 

Zoe Dunn
Zoe Dunn, President and CEO of Hale Advisors, is a digital marketing and communications specialist with over twenty years of experience in the field. She has extensive experience in both the agency and commercial marketing side of the pharmaceutical, medical devices, and biotech industries.

Comments are closed.